S

在45只切断双侧缓冲神经的Sprague-Dawley 大鼠,应用细胞外记录方法, 观察了颈动脉内注射腺苷对76 个最后区 (AP) 神经元自发放电活动的影响。所得结果如下(1) 在记录到的42个自发放电单位中, 颈动脉内注射腺苷(25 μg/kg) 引起其中29个单位的放电频率由6.26±0.75 下降至4.74±0.76 spikes/s (P<0.01), 6 个单位放电频率由4.13±0.77增加至4.72±0.83 spikes/s (P<0.05),另外7个单位放电频率无明显变化, 而血压和心率在实验中无变化; (2)在应用非选择性腺苷受体拮抗剂8-苯茶碱(8-phenyltheophylline, 15 μg/kg) 的10个单位, 腺苷对放电的抑制效应可被完全阻断; (3) 应用选择性腺苷A     

17β-雌二醇对大鼠脑片穹隆下器神经元放电活动的调变作用

用细胞外记录技术 ,在大鼠脑片穹隆下器 (subfornicalorgan ,SFO)上观察了 17β 雌二醇 (17β estradiol,E2 )对SFO神经元放电的影响 ,并进而分析其作用机制。实验结果如下 :(1) 15个SFO神经元在给予小剂量E2(0 1nmol/L)时 ,放电频率由 3 2 1± 0 37增至 6 79± 0 71Hz(P <0 0 0 1) ;而在给予大剂量E2 (10 0nmol/L)时 ,则放电频率由 3 44± 0 40Hz降至 1 44± 0 36Hz (P <0 0 1) ;(2 )在 7个SFO神经元应用谷氨酸NMDA受体阻断剂MK 80 1(5 0pmol/L) ,可阻断小剂量E2 (0 1nmol/L)对SFO神经元的兴奋效应 ;(3)在 7个SFO神经元应用NO生理性前体L 精氨酸 (L arginine ,1mmol/L)时 ,SFO神经元放电减少 ,且可阻断小剂量E2 (0 1nmol/L)对神经元的兴奋效应 ;(4 )在 6个SFO神经元应用NOS抑制剂L NG 硝基精氨酸甲酯 (L NAME ,10mmol)引起SFO神经元放电增加 ,并阻断大剂量E2 (10 0nmol/L)对SFO神经元的抑制效应。结果提示 :E2 对SFO神经元有双重作用。小剂量E2 使SFO神经元放电增加 ,这一效应可能与谷氨酸受体激活有关 ;而大剂量E2 则导致神经元放电减少 ,此效应可归因于NOS激活而引发NO生成。     

颈动脉注射肾上腺髓质素对去缓冲神经大鼠最后区神经元自发放电的影响

在63只切断两侧缓冲神经的麻醉sprague-Dawley大鼠,应用细胞外记录的电生理学方法,观察颈内动脉注射肾上腺髓质素(adrenomedullin,AM)对最后区(area postrema,AP)神经元自发电活动的影响。实验结果如下:(1)在记录到的78个自发放电单位中,颈内动脉内注射AM(0.3 nmol/kg),引起其中47个单位的自发放电频率由2.99±0.24增加到4.79±0.29 spikes/s(P<0.001),20个单位自发放电频率由3.24±0.46下降至1.97±0.37 spikes/s(P<0.001),另外11个单位自发放电频率无明显改变;平均动脉压和心率无明显变化。(2)颈内动脉注射降钙素基因相关肽受体阻断剂CGRP_(8-37)(3 nmol/kg)不能改变AM对自发放电的兴奋效应;(3)颈内动脉注射L-精氨酸(30 mg/kg)可减弱AM对自发放电的兴奋效应。以上结果提示,AM对最后区神经元有兴奋作用,此作用不是由降钙素基因相关肽受体介导,但可被NO前体L-精氨酸所减弱。     

颈动脉注射腺苷对去缓冲神经大鼠延髓腹外侧头端区神经元放电的影响

在28只切断双侧缓冲神经的Sprague－Dawley大鼠,应用细胞外记录方法,观察了72个自发放电单位中颈动脉注射腺苷对延髓腹外侧头端（RVLM）区神经元自发放电活动的影响。所得结果如下：（1）颈动脉注射腺苷（25μg/kg）,31个单位的放电频率由23．5±3．0下降至（16．5±2．6）spikes／s（P＜0．001）,血压和心率无明显变化（P＞0．05）;（2）在24个单位中,应用非选择性腺苷受体拮抗剂8-苯茶碱（8-phenyltheophylline,15μg/kg）和选择性腺苷A1受体持抗剂8-环戊-1,3-二丙基黄嘌呤（8－cyclopentyl-1,3－dipropylxanthine,50μg/kg）均可完全阻断腺苷的抑制效应;（3）在应用ATP敏感性钾通道阻断剂格列苯脲（500μg/kg）的12个单位中,腺苷的上述效应亦被消除。以上结果提示,腺苷对RVLM区神经元自发放电有抑制作用,而此作用与A1受体介导的ATP敏感性钾通道开放有关。     

延髓腹侧结构在刺激缰核诱发升压反应中的作用

电刺激缰核(Hb)可使大鼠血压明显升高,但心率变化不明显。电刺激Hb血压升高的同时,延髓腹侧结构(VM)中46.5％的神经元自发放电频率增加,这些神经元分布在VM的升压神经元群中,41.9％的神经元自发放电频率降低,这些神经元分布在VM的降压神经元群中,11.6%的神经元自发放电频率不变,升压和降压神经元群中均有这种神经元。单侧损毁VM的网状旁巨细胞核后,动物血压基本不变,也不影响电刺激Hb引起的升压反应。双侧损毁VM的网状旁巨细胞核后,动物血压从98.4±11.2mmHg降至45.2±10.3mmHg,阻断了电刺激Hb引起的升压反应。单侧或双恻损毁疑核及部分延髓网状核腹侧后,动物血压基本不变,且不影响电刺激Hb引起的升压反应。 上述结果表明,Hb主要通过VM中升压神经元群的网状旁巨细胞核参与心血管活动的调节。     

颈动脉内注射腺苷对去缓冲神经大鼠最后区神经元放电的影响

在45只切断双侧缓冲神经的SpragueDawley大鼠,应用细胞外记录方法,观察了颈动脉内注射腺苷对76个最后区(AP)神经元自发放电活动的影响。所得结果如下:(1)在记录到的42个自发放电单位中,颈动脉内注射腺苷(25μg/kg)引起其中29个单位的放电频率由626±075下降至474±076spikes/s(P<001),6个单位放电频率由413±077增加至472±083spikes/s(P<005),另外7个单位放电频率无明显变化,而血压和心率在实验中无变化;(2)在应用非选择性腺苷受体拮抗剂8苯茶碱(8phenyltheophylline,15μg/kg)的10个单位,腺苷对放电的抑制效应可被完全阻断;(3)应用选择性腺苷A1受体拮抗剂8环戊1,3二丙基黄嘌呤(8cyclopentyl1,3dipropylxanthine,50μg/kg)亦可有效地阻断腺苷对12个单位的抑制效应;(4)应用ATP敏感性钾通道阻断剂格列苯脲(500μg/kg)的12个单位,腺苷的上述效应也被消除。以上结果提示,腺苷对AP区神经元自发放电有抑制作用,而此作用与A1受体介导的ATP敏感性钾通道开放有关。     

17β-雌二醇抑制雄性大鼠颈动脉窦压力感受器反射

采用隔离灌流麻醉雄性大鼠颈动脉窦技术 ,观察了 17β 雌二醇 (E2 )对颈动脉窦压力感受器反射的影响。结果如下 :(1)以E2 (10 μmol/L)隔离灌流颈动脉窦区时 ,压力感受器机能曲线向右上方移位 ,曲线最大斜率(peakslope,PS)由 0 49± 0 0 3降至 0 2 5± 0 0 1(P <0 0 1) ,反射性血压下降幅度 (reflexdecrease,RD)由 7 37± 0 42kPa降至 3 49± 0 2 0kPa (P <0 0 0 1) ,阈压 (thresholdpressure ,TP)和饱和压 (saturationpressure ,SP)分别由 9 5 2±0 6 8kPa和 2 4 5 3± 0 48kPa增至 13 3± 0 11kPa (P <0 0 0 1)和 2 7 5 2± 0 2 0kPa (P <0 0 1) ,其中PS、RD、TP和SP呈明显的剂量依赖性 ;(2 )用雌激素受体阻断剂tamoxifen (1、5、10、30 μmol/L)预处理后 ,不能阻断E2 对压力感受器反射的抑制作用 ;(3)预先灌流NO合酶阻断剂 (L NAME ,10 0 μmol/L) ,可完全消除E2 (10 μmol/L)对压力感受器反射的抑制效应。以上结果表明 ,17β 雌二醇可通过非基因组机制抑制大鼠颈动脉窦压力感受器反射 ,其效应系E2 引起血管内皮细胞释放NO所致。     

最后区注射腺苷对大鼠血压、心率和肾交感神经放电的影响

在 5 3只麻醉Sprague Dawley大鼠观察了最后区内微量注射腺苷 (1ng/ 6 0nl)对平均动脉压 (MAP)、心率(HR)和肾交感神经放电 (RSNA)的影响。实验结果如下 :(1)最后区内微量注射Ado后 ,MAP、HR和RSNA分别由13 76± 0 46kPa、35 6 2 8± 4 2 5bpm和 10 0± 0 %下降至 11 2 3± 0 49kPa (P <0 0 0 1)、336 91± 5 2 3bpm (P <0 0 1)和70 95± 5 19% (P <0 0 0 1) ;(2 )静脉注射非选择性腺苷受体拮抗剂 8 苯茶碱 (8 phenyltheophylline,15 0 μg/kg ,0 2ml)和选择性腺苷A1受体拮抗剂 (8 cyclopentyl 1,3 dipropylxanthine,5 0 0 μg /kg ,0 2ml)后 ,腺苷的上述抑制效应可被完全阻断 ;(3)静脉注射ATP敏感性钾通道阻断剂格列苯脲 (5mg/kg ,0 2ml)后 ,腺苷的上述效应也被消除。以上结果提示 ,最后区微量注射腺苷对血压、心率和肾交感神经放电有抑制作用 ,此作用与A1受体介导的ATP敏感性钾通道开放有关。     

肾缺血增强大鼠延髓腹外侧头端区神经元电话动和Fos蛋白表达

在67只切断两侧缓冲神经的麻醉Sprague-Dawley大鼠,应用细胞外记录的电生理方法和免疫组织化学技术,分别观察肾缺血对延髓腹外侧头端区巨细胞旁外侧核神经元自发放电活动和Fos蛋白表达的影响.所得结果如下(1)左肾动脉阻断后,28个单位的放电频率由11.40±1.08增至21.1±1.74spikes/s(P<0.001),血压和心率无明显变化(P>0.05);(2)在17个放电单位中,应用腺苷受体拮抗剂8-苯茶碱(8-phenyltheophylline,10mg/kg)可明显抑制肾缺血的兴奋效应(P<0.05);(3)肾缺血后,延髓腹外侧头端区的Fos蛋白样免疫反应神经元显著增加(P<0.01);(4)预先应用8-苯茶碱可明显减弱肾缺血所激活的Fos蛋白表达反应(P<0.05).以上结果提示肾缺血增强延髓腹外侧头端区神经元的放电活动和Fos蛋白表达,而此作用可能与肾脏缺血所产生的腺苷激活肾内感受器有关.     

芦沙坦的降压效应和内、外侧缰核神经元单位放电的关系

目的和方法 :观察腹腔注射 (i.p) 2mg kg和 10mg kg芦沙坦 (losartan)对大鼠股动脉血压 (aterialbloodpressure ,AP)和心率 (heartrate,HR)的影响以及与缰核 (Hb)神经元活动的关系。用玻璃微电极记录内侧缰核 (MHb)、外侧缰核(LHb)神经元单位放电活动 ,观察 10mg kg芦沙坦对其放电频率的影响。结果 :2mg kg芦沙坦对大鼠AP和HR无明显影响 ;(10mg kg芦沙坦可显著降低大鼠动脉血压 ,但对心率无明显影响。 10mg kg芦沙坦可使LHb内 6 6 6 6 % 12 18)神经元单位放电频率增加 ,使MHb内 6 1 90 % (13 2 1)神经元单位放电频率减少。结论 :10mg kg芦沙坦可明显地降低大鼠AP ,但 2mg kg芦沙坦对AP无明显影响 ;10mg kg芦沙坦可兴奋LHb和抑制MHb,产生降压效应     

内皮素通过最后区易化大鼠延髓腹外侧头端区神经元活动

在３５只切断双侧缓冲神经、用氨基甲酸乙酯－α氯醛糖混合麻醉的Ｓｐｒａｇｕｅ－Ｄａｗｌｅｙ大鼠,应用细胞外记录的电生理学方法,由ＲＭ－６０００型多道生理记录仪和ＷＳ－６８２Ｇ热阵记录器（频响范围０～２．８ｋＨｚ）同步记录血压、心率和单位神经元放电,观察颈动脉注射内皮素对８７个延髓腹是头端区（ＲＶＬＭ）自发放电神经元活动的影响,所得结果如下;（１）颈动脉注射ＥＴ－１（０．３ｎｍｏｌ／ｋｇ）时３６个单位     

颈动脉内注射腺苷对去缓冲神经大鼠最后区神圣凶放电影响

To observe the effect of intracarotid administration of adenosine on the electrical activity of area postrema (AP) neurons, 76 spontaneous active units were recorded from 45 sino-aortic denervated Sprague-Dawley rats using extracellular recording technique. The results obtained are as follows. (1) Following intracarotid administration of adenosine (Ado, 25 micrograms/kg), the discharge rate of 29 out of 42 units decreased markedly from 6.26 +/- 0.75 to 4.74 +/- 0.76 spikes/s (P < 0.01), whereas that of 6 units increased from 4.13 +/- 0.77 to 4.72 +/- 0.83 spikes/s (P < 0.05), and the other 7 showed no response. Blood pressure (BP) and heart rate (HR) were unaltered throughout the experiment. (2) 8-phenyltheophylline (8-PT, 15 micrograms/kg), a nonselective adenosine receptor antagonist, completely blocked the inhibitory effect of Ado in 10 units. (3) Selective A1 adenosine receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, 50 micrograms/kg), blocked the effect of Ado in 12 units to a remarkable extent. (4) Glibenclamide (500 micrograms/kg), a blocker of ATP-sensitive potassium channel, abolished the effect of Ado in 12 units. The above results indicate that Ado can inhibit spontaneous electrical activity of AP neurons, which is mediated by adenosine A1-receptor with the involvement of ATP-sensitive potassium channels.     

Inhibitory effects of propofol on neuron firing activities in the rostral ventrolateral medulla

The effect of propofol on neuronal activity in the rostral ventrolateral medulla (RVLM) is not well established. Therefore, we performed extracellular recording on neurons of the RVLM to investigate neuronal activity before and after administration of intravenous propofol. The mean systemic arterial pressure (MSAP), heart rate and integrated neuronal firing rate (INFR) in the RVLM were continuously recorded in anesthetized cats before and after intravenous injection of 2 mg/kg propofol or supplemental injections of 1, 2 and 4 mg/kg propofol that were given respectively. Additionally, we compared the MSAP, heart rate (HR), and INFR in the RVLM following intravenous injection of 2 mg/kg propofol or 12.5 microg/kg nitroprusside. Neuronal firing was dose-dependently and reversibly inhibited after the supplemental doses of 1, 2 and 4 mg/kg propofol. The control INFR was 14.2 +/- 9.9 Hz, and this decreased to 12.1 +/- 9.4 Hz after the first dose of propofol (P = 0.085 vs. control), and further decreased to 9.3 +/- 7.7 Hz (P = 0.001 vs. control) and 7.5 +/- 7.7 Hz (P < 0.001 vs. control) after the second and third doses of propofol, respectively. Besides, SAP and HR were dose-dependently decreased by propofol as well. However, the effects of propofol and nitroprusside on neuronal activity in the RVLM differed. Propofol inhibited neuronal firing, whereas nitroprusside activated neuronal firing. In conclusion, propofol may dose-dependently inhibit spontaneous neuronal activity and the baroreflex in the RVLM.     

辣椒素对大鼠延髓腹外侧头端区神经元电活动的影响

在35只切断两侧缓冲神经的麻醉大鼠,应用细胞外记录的电生理学方法,观察颈总动脉注射辣椒素(capsaicin)对延髓腹外侧头端区(RVLM)巨细胞旁外侧核(PGL)自发电活动的影响。所得结果如下:(1)颈动脉注射辣椒素(10μmol,01ml),MAP由1074±013升至1256±021kPa(P<0001);HR由374±4增至395±5bpm(P<0001);30个PGL神经元自发放电单位的放电频率由126±07增至209±11spikes/s(P<0001)。(2)在10个放电单位,应用辣椒素受体阻断剂钌红(rutheniumred;200mmol,01ml)后,明显抑制辣椒素的上述效应。以上结果提示,辣椒素可能通过激活RVLM神经元上的辣椒素受体,进而兴奋PGL神经元     

Pregnancy increases baroreflex-independent GABAergic inhibition of the RVLM in rats

During baroreceptor unloading, sympathoexcitation is attenuated in near-term pregnant compared with nonpregnant rats. Alterations in balance among different excitatory and inhibitory inputs within central autonomic pathways likely contribute to changes in regulation of sympathetic outflow in pregnancy. Both baroreflex-dependent and baroreflex-independent GABAergic inputs inhibit sympathoexcitatory neurons within rostral ventrolateral medulla (RVLM). The present experiments tested the hypothesis that influence of baroreflex-independent GABAergic inhibition of RVLM is greater in pregnant compared with nonpregnant rats. Afferent baroreceptor inputs were eliminated by bilateral sinoaortic denervation in inactin-anesthetized rats. In pregnant compared with nonpregnant rats, baseline mean arterial pressure (MAP) was lower (pregnant = 75 +/- 6 mmHg, nonpregnant = 115 +/- 7 mmHg) and heart rate was higher (pregnant = 381 +/- 10 beats/min, nonpregnant = 308 +/- 10 beats/min). Pressor and sympathoexcitatory [renal sympathetic nerve activity, (RSNA)] responses due to bilateral GABA(A) receptor blockade (bicuculline, 4 mM, 100 nl) of the RVLM were greater in pregnant rats (delta MAP: pregnant = 101 +/- 4 mmHg, nonpregnant = 80 +/- 6 mmHg; delta RSNA: pregnant = 182 +/- 23% control, nonpregnant = 133 +/- 10% control). Unexpected transient sympathoexcitatory effects of angiotensin AT(1) receptor blockade in the RVLM were greater in pregnant rats. Although excitatory responses to bicuculline were attenuated by prior RVLM AT1 receptor blockade in both groups, pressor responses to disinhibition of the RVLM remained augmented in pregnant rats. Increased influence of baroreflex-independent GABAergic inhibition in RVLM could contribute to suppressed sympathoexcitation during withdrawal of arterial baroreceptor input in pregnant animals.     

CCK-induced inhibition of presympathetic vasomotor neurons: dependence on subdiaphragmatic vagal afferents and central NMDA receptors in the rat

Systemic administration of cholecystokinin (CCK) inhibits a subpopulation of rostral ventrolateral medulla (RVLM) presympathetic vasomotor neurons. This study was designed to determine whether this effect involved subdiaphragmatic vagal afferents and/or central N-methyl-d-aspartic acid (NMDA) receptors. Recordings were made from CCK-sensitive RVLM presympathetic vasomotor neurons in halothane-anesthetized, paralyzed male Sprague-Dawley rats. The responses of the neurons to CCK (2 and 4 microg/kg iv), phenylephrine (PE; 5 microg/kg iv), and phenylbiguanide (PBG; 5 microg/kg iv) were tested before and after application of the local anesthetic lidocaine (2% wt/vol gel; 1 ml) to the subdiaphragmatic vagi at the level of the esophagus. In seven separate experiments, lidocaine markedly reduced the inhibitory effects of CCK on RVLM presympathetic neuronal discharge rate. In other experiments, the effect of systemic administration of dizocilpine (1 mg/kg iv), a noncompetitive antagonist at NMDA receptor ion channels, on the RVLM presympathetic neuronal responses to CCK, PBG, and PE was tested. In all cases (n = 6 neurons in 6 individual rats), dizocilpine inhibited the effects of CCK, PBG, and PE on RVLM presympathetic neuronal discharge. These results suggest that the effects of systemic CCK on the discharge of RVLM presympathetic neurons is mediated via an action on receptors located on subdiaphragmatic vagal afferents. Furthermore, the data suggest that CCK activates a central pathway involving NMDA receptors to produce inhibition of RVLM presympathetic neuronal discharge.     

Cholecystokinin selectively affects presympathetic vasomotor neurons and sympathetic vasomotor outflow

Cholecystokinin (CCK) is a potential mediator of gastrointestinal vasodilatation during digestion. To determine whether CCK influences sympathetic vasomotor function, we examined the effect of systemic CCK administration on mean arterial blood pressure (MAP), heart rate (HR), lumbar sympathetic nerve discharge (LSND), splanchnic sympathetic nerve discharge (SSND), and the discharge of presympathetic neurons of the rostral ventrolateral medulla (RVLM) in alpha-chloralose-anesthetized rats. CCK (1-8 microg/kg iv) reduced MAP, HR, and SSND and transiently increased LSND. Vagotomy abolished the effects of CCK on MAP and SSND as did the CCK-A receptor antagonist devazepide (0.5 mg/kg iv). The bradycardic effect of CCK was unaltered by vagotomy but abolished by devazepide. CCK increased superior mesenteric arterial conductance but did not alter iliac conductance. CCK inhibited a subpopulation (approximately 49%) of RVLM presympathetic neurons whereas approximately 28% of neurons tested were activated by CCK. The effects of CCK on RVLM neuronal discharge were blocked by devazepide. RVLM neurons inhibited by exogenous CCK acting via CCK-A receptors on vagal afferents may control sympathetic vasomotor outflow to the gastrointestinal tract vasculature.